Vera Therapeutics, Inc. <VERA.O>: Wedbush cuts target price to $34 from $43
VERA•Related News
LB Pharmaceuticals Q2 FY26 net loss widens to $51.6 million
LBRX•
Theriva Biologics Q2 net loss narrows on lower R&D costs, expenses
TOVX•
Imunon Q2 net loss widens slightly as R&D costs rise
IMNN•
Axsome Therapeutics, Inc. <AXSM.O>: Morgan Stanley raises target price to $251 from $242
AXSM•
UK MHRA expands Rhythm’s IMCIVREE authorization to treat acquired hypothalamic obesity
RYTM•